Risk factors for glioblastoma therapy associated complications
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 134, 55-59
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaThe Lancet Oncology, 2014
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2014
- Comorbid conditions associated with glioblastomaJournal of Neuro-Oncology, 2014
- Establishing standard performance measures for adult brain tumor patients: a nationwide inpatient sample database studyNeuro-Oncology, 2013
- Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studiesMedical Oncology, 2012
- The Risk of Getting Worse: Surgically Acquired Deficits, Perioperative Complications, and Functional Outcomes After Primary Resection of GlioblastomaWorld Neurosurgery, 2011
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 casesBritish Journal Of Neurosurgery, 2007
- The WHO Classification of Tumors of the Nervous SystemJournal of Neuropathology & Experimental Neurology, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987